Biora Therapeutics Stock Price Prediction
| BIOR Stock | USD 1.93 0.14 7.82% |
Oversold Vs Overbought
27
Oversold | Overbought |
EPS Estimate Next Quarter (3.70) | Wall Street Target Price 34 | EPS Estimate Current Quarter (3.85) | Quarterly Revenue Growth 158 |
Using Biora Therapeutics hype-based prediction, you can estimate the value of Biora Therapeutics from the perspective of Biora Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Biora Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Biora because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Biora Therapeutics after-hype prediction price | USD 1.36 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Biora |
Biora Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Biora Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biora Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biora Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biora Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Biora Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biora Therapeutics' historical news coverage. Biora Therapeutics' after-hype downside and upside margins for the prediction period are 0.07 and 8.02, respectively. We have considered Biora Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biora Therapeutics is slightly risky at this time. Analysis and calculation of next after-hype price of Biora Therapeutics is based on 3 months time horizon.
Biora Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Biora Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biora Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biora Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.79 | 6.66 | 0.57 | 0.01 | 7 Events / Month | 8 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.93 | 1.36 | 29.53 |
|
Biora Therapeutics Hype Timeline
Biora Therapeutics is currently traded for 1.93. The entity has historical hype elasticity of -0.57, and average elasticity to hype of competition of 0.01. Biora is estimated to decline in value after the next headline, with the price expected to drop to 1.36. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -29.53%, whereas the daily expected return is currently at -1.79%. The volatility of related hype on Biora Therapeutics is about 183150.0%, with the expected price after the next announcement by competition of 1.94. About 29.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Biora Therapeutics had 1:10 split on the 18th of October 2024. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Biora Therapeutics Basic Forecasting Models to cross-verify your projections.Biora Therapeutics Related Hype Analysis
Having access to credible news sources related to Biora Therapeutics' direct competition is more important than ever and may enhance your ability to predict Biora Therapeutics' future price movements. Getting to know how Biora Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biora Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CWBR | CohBar Inc | 0.07 | 3 per month | 5.34 | 0.08 | 5.73 | (5.59) | 250.97 | |
| ENVB | Enveric Biosciences | 0.08 | 6 per month | 0.00 | (0.16) | 6.25 | (7.50) | 28.33 | |
| ELEV | Elevation Oncology | (0.02) | 9 per month | 0.00 | (0.08) | 5.77 | (8.22) | 22.21 | |
| HEPA | Hepion Pharmaceuticals | (0.02) | 4 per month | 0.00 | (0.05) | 8.06 | (8.11) | 33.54 | |
| ZURA | Zura Bio Limited | (0.12) | 9 per month | 0.00 | (0.09) | 7.95 | (7.94) | 26.70 | |
| OCEA | Ocean Biomedical | 0.02 | 3 per month | 0.00 | (0.1) | 7.46 | (6.93) | 28.33 | |
| AVRO | AVROBIO | 0.05 | 5 per month | 1.89 | 0.01 | 4.11 | (3.17) | 14.20 | |
| EFTR | Effector Therapeutics | (0.06) | 4 per month | 0.00 | (0.31) | 8.70 | (27.78) | 88.91 | |
| VIRI | Virios Therapeutics Llc | 0.14 | 5 per month | 0.00 | (0.06) | 12.46 | (10.62) | 50.54 | |
| NAVB | Navidea Biopharmaceuticals | 0.00 | 0 per month | 0.00 | (0.15) | 12.50 | (12.50) | 40.40 | |
| ZVSA | ZyVersa Therapeutics | (0.1) | 4 per month | 0.00 | (0.15) | 7.57 | (9.60) | 78.93 |
Biora Therapeutics Additional Predictive Modules
Most predictive techniques to examine Biora price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biora using various technical indicators. When you analyze Biora charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Biora Therapeutics Predictive Indicators
The successful prediction of Biora Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biora Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biora Therapeutics based on analysis of Biora Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biora Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biora Therapeutics's related companies. | 2023 | 2024 (projected) | Dividend Yield | 6.69E-4 | 5.94E-4 | Price To Sales Ratio | 53.2K | 55.9K |
Story Coverage note for Biora Therapeutics
The number of cover stories for Biora Therapeutics depends on current market conditions and Biora Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biora Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biora Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Biora Therapeutics Short Properties
Biora Therapeutics' future price predictability will typically decrease when Biora Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biora Therapeutics often depends not only on the future outlook of the potential Biora Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biora Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.8 M | |
| Cash And Short Term Investments | 15.2 M |
Additional Tools for Biora Stock Analysis
When running Biora Therapeutics' price analysis, check to measure Biora Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biora Therapeutics is operating at the current time. Most of Biora Therapeutics' value examination focuses on studying past and present price action to predict the probability of Biora Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biora Therapeutics' price. Additionally, you may evaluate how the addition of Biora Therapeutics to your portfolios can decrease your overall portfolio volatility.